| 121 | 180413appendix 4g and corporate governance statement | |
| 122 | 180413annual report to shareholders | |
| 123 | eve omni innovation enters chinese distribution agreement | |
| 124 | eagle health to target china diabetes market | |
| 125 | eagle health edges closer to ipo with extra $10m from sa nutritions group | |
| 126 | eagle health - switzer super report 150517 | |
| 127 | dividend reinvestment plan | |
| 128 | dividend reinvestment plan rules final 30 august | |
| 129 | distribution agreement with biovite australia | |
| 130 | 1213release of shares from escrow | |
| 131 | 1207eagle health begins shipment of new diabetes product | |
| 132 | 1123 2016 dividend payment update china shareholders | |
| 133 | 1031production development for diabetes pre-meal shake | |
| 134 | 1026appendix 3b and 708a notice - drp | |
| 135 | 1023eagle health & amka initiate first round of projects | |
| 136 | 0922eagle health to target china diabetes market | |
| 137 | 0913release of shares from escrow | |
| 138 | 0913investor presentation | |
| 139 | 0907eagle health & amka sign heads of agreement | |
| 140 | 0905response to asx query | |
